RARRES2 and portal hypertension: Notably, serum chemerin predicted short-term transplant-free mortality and correlated primarily with surrogates of impaired hepatic function and portal hypertension but not with extrahepatic organ failure, bacterial infection or the severity of systemic inflammation.